Sporadic and Familial Amyotrophic Lateral Sclerosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Sporadic and Familial Amyotrophic Lateral Sclerosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT05923905

Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

This is a randomized double-blind controlled exploratory clinical study to evaluate the efficacy and safety of FB1006 in the treatment of amyotrophic lateral sc…

China64 participantsStarted 2023-01-18

Treatment: FB1006, Placebo

All recent trials (13 shown)

Active — Not RecruitingNot Applicable

NCT05928416

ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

RNALS is a multicentre, transversal, diagnostic and non-interventional study carried out in ALS reference centers; in order to identify a diagnostic signature f…

France653 participantsStarted 2023-07-11

Treatment: Saliva sample, Saliva sample

TerminatedPhase 1

NCT06215755

A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

The primary purpose of this study is to evaluate the safety and tolerability of VRG50635 in participants with ALS.

Belgium, Canada, Finland54 participantsStarted 2024-01-15

Treatment: VRG50635

Sporadic and Familial Amyotrophic Lateral Sclerosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

All recent trials (13 shown)

ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

All recent trials (13 shown)

ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participa…

Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS

Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders

SOD1 Kinetics Measurements in ALS Patients

Genetics of Familial and Sporadic ALS

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)

Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS

A Study to Evaluate AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)

Dual Treatment With Lithium and Valproate in ALS.

Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis